Volume 39, Issue 1

Search all Glycoconjugate Journal articles

February 2022

Special issue on The Glycobiology of Parkinson’s disease (pages 1-82)

Issue Editors:

Elena Chiricozzi,
Sandro Sonnino

10 articles in this issue

Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease
Nouara Yahi
Coralie Di Scala
Jacques Fantini
Comprehensive Review Article 30 July 2021 Pages: 1 - 11
Part of 2 collections:

The Glycobiology of Parkinson’s disease

The Glycobiology of Parkinson’s disease
A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson’s disease
J. S. Schneider
Comprehensive Review Article 26 May 2021 Pages: 13 - 26
Part of 2 collections:

The Glycobiology of Parkinson’s disease

The Glycobiology of Parkinson’s disease
Novel insights on GM1 and Parkinson's disease: A critical review
Maria Fazzari
Erika Di Biase
Sandro Sonnino
Comprehensive Review Article Open access 22 January 2022 Pages: 27 - 38
Part of 2 collections:

The Glycobiology of Parkinson’s disease

The Glycobiology of Parkinson’s disease
Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
Kerri-Lee Wallom
María E. Fernández-Suárez
Frances M. Platt
Comprehensive Review Article Open access 10 November 2021 Pages: 39 - 53
Glycoconjugate journal special issue on: the glycobiology of Parkinson’s disease
Inka Brockhausen
John Schutzbach
Jennifer Brockhausen
Comprehensive Review Article 10 November 2021 Pages: 55 - 74
Systemic deficiency of GM1 ganglioside in Parkinson’s disease tissues and its relation to the disease etiology
Robert Ledeen
Suman Chowdhury
Gusheng Wu
Original Article Open access 01 January 2022 Pages: 75 - 82
35 years in plant lectin research: a journey from basic science to applications in agriculture and medicine
Els J. M. Van Damme
2021 IGO Award 24 August 2021 Pages: 83 - 97
Plasma membrane glycosphingolipid signaling: a turning point
Elena Chiricozzi
2021 IGO Young Glycoscientist Award Open access 16 August 2021 Pages: 99 - 105
Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration
Patricia Marques Pereira
Dulce Papy-Garcia
Jean-Christophe Cassel
Original Article Open access 07 March 2022 Pages: 107 - 130
A galacturonan from Dioscorea opposita Thunb. regulates fecal and impairs IL-1 and IL-6 expression in diarrhea mice
Hao-Yu Pan
Chun-Qian Zhang
Kan Ding
Original Article 14 March 2022 Pages: 131 - 141

Volume 39, Issue 1

Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease

A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson’s disease

Novel insights on GM1 and Parkinson's disease: A critical review

Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease

Glycoconjugate journal special issue on: the glycobiology of Parkinson’s disease

Systemic deficiency of GM1 ganglioside in Parkinson’s disease tissues and its relation to the disease etiology

35 years in plant lectin research: a journey from basic science to applications in agriculture and medicine

Plasma membrane glycosphingolipid signaling: a turning point

Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration

A galacturonan from Dioscorea opposita Thunb. regulates fecal and impairs IL-1 and IL-6 expression in diarrhea mice

Navigation